Annual Drug Patent Expirations for KRAZATI
Krazati is a drug marketed by Mirati Theraps and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
This drug has twenty-eight patent family members in twenty-eight countries.
The generic ingredient in KRAZATI is adagrasib. One supplier is listed for this compound. Additional details are available on the adagrasib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com